Internationale Publikationen
Hier stellen wir eine Auswahl wissenschaftlicher Veröffentlichungen zur Verfügung, die im Zusammenhang mit der IOZK-Immuntherapie stehen.
Sie können mit Hilfe der Filter eine Auswahl nach Tumorarten und Methoden treffen, oder Suchbegriffe eingeben.
Myeloid and plasmacytoid dendritic cell vaccinations for castration-resistant prostate cancer patients.
/in Dendritic Cells, International Publications, Prostate Cancer /von 2018-02-08 / J Clin Oncol 36, 2018 (suppl 6S; abstr 219)Re-Emergence of Dendritic Cell Vaccines for Cancer Treatment
/in Dendritic Cells, International Publications /von 2018-02-01 / Trends Cancer 2018 02;4(2):119-137Pre-existing Immunity to Oncolytic Virus Potentiates Its Immunotherapeutic Efficacy
/in International Publications, Newcastle Disease Virus /von 2018-01-31 / Mol. Ther. 2018 04;26(4):1008-1019Radiation and Anti-Cancer Vaccines: A Winning Combination
/in Dendritic Cells, International Publications /von 2018-01-30 / Vaccines (Basel) 2018 Jan;6(1)Survival gain in glioblastoma patients treated with dendritic cell immunotherapy is associated with increased NK but not CD8 T cell activation in the presence of adjuvant temozolomide
/in Dendritic Cells, Glioblastoma, International Publications /von 2018-01-29 / Oncoimmunology 2018;7(4):e1412901Autologous tumor lysate-pulsed dendritic cell vaccination therapy after resection of stage IIA (T2N0, T3N0) esophageal cancer: An analysis of immunological responses.
/in Dendritic Cells, Esophageal Carcinoma, International Publications /von 2018-01-26 / J Clin Oncol 36, 2018 (suppl 5S; abstr 96)A prospective, randomized, blinded, placebo-controlled, phase IIb trial of an autologous tumor lysate + yeast cell wall particles (YCWP) + dendritic cells (DC) vaccine vs unloaded YCWP + DC and embedded phase I/IIa trial with tumor lysate particle only (TLPO) vaccine in stage III and stage IV (resected) melanoma to prevent recurrence.
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2018-01-25 / J Clin Oncol 36, 2018 (suppl 5S; abstr TPS201)The effect of modulated electro-hyperthermia on temperature and blood flow in human cervical carcinoma
/in Cervical Cancer, Hyperthermia, International Publications /von 2018-01-21 / Int J Hyperthermia 2018 11;34(7):953-960Hyperthermia enhances radiosensitivity of colorectal cancer cells through ROS inducing autophagic cell death
/in Colorectal Cancer, Hyperthermia, International Publications /von 2018-01-11 / J. Cell. Biochem. 2018 04;119(4):3763-3774A phase-1/2 study of adenovirus-p53 transduced dendritic cell vaccine in combination with indoximod in metastatic solid tumors and invasive breast cancer
/in Breast Cancer, Dendritic Cells, International Publications /von 2018-01-10 / Oncotarget 2018 Feb;9(11):10110-10117Newcastle disease virus co-expressing interleukin 7 and interleukin 15 modified tumor cells as a vaccine for cancer immunotherapy
/in International Publications, Newcastle Disease Virus /von 2018-01-09 / Cancer Sci. 2018 Feb;109(2):279-288EpCAM peptide-primed dendritic cell vaccination confers significant anti-tumor immunity in hepatocellular carcinoma cells
/in Dendritic Cells, Hepatocellular Carcinoma, International Publications /von 2018-01-03 / PLoS ONE 2018;13(1):e0190638Intravenous delivery of oncolytic reovirus to brain tumor patients immunologically primes for subsequent checkpoint blockade
/in Checkpoint-Inhibitors, International Publications, Newcastle Disease Virus /von 2018-01-03 / Sci Transl Med 2018 01;10(422)Buch Veröffentlichung von Prof. Dr. Schirrmacher: Quo vadis cancer therapy
/0 Kommentare/in IOZK Meldungen, IOZK Veröffentlichungen /von IOZKModulated electro-hyperthermia induced loco-regional and systemic tumor destruction in colorectal cancer allografts
/in Colorectal Cancer, Hyperthermia, International Publications /von 2018-01-01 / J Cancer 2018;9(1):41-53Phase I clinical trial of a novel autologous modified-DC vaccine in patients with resected NSCLC
/in Dendritic Cells, International Publications, NSCLC /von 2017-12-21 / BMC Cancer 2017 12;17(1):884Antitumor Benefits of Antiviral Immunity: An Underappreciated Aspect of Oncolytic Virotherapies
/in International Publications, Newcastle Disease Virus /von 2017-12-20 / Trends Immunol. 2018 03;39(3):209-221Autologous Dendritic Cells Pulsed with Allogeneic Tumor Cell Lysate in Mesothelioma: From Mouse to Human
/in Dendritic Cells, International Publications, Malignant Pleural Mesothelioma /von 2017-12-12 / Clin. Cancer Res. 2018 Feb;24(4):766-776Advances in immunotherapeutic research for glioma therapy
/in Dendritic Cells, Glioblastoma, International Publications /von 2017-12-05 / J. Neurol. 2018 Apr;265(4):741-756Immunotherapy in pancreatic ductal adenocarcinoma: an emerging entity?
/in International Publications, Pancreatic Cancer /von 2017-12-01 / Ann. Oncol. 2017 Dec;28(12):2950-2961